| Time (weeks) |  − 2 | 0 and 18 | 4 and 22 | 6,8,13 and 24,26,31 | 18 and 36 |
---|---|---|---|---|---|---|
 | Period (1 or 2) | 1 | 1 and 2 | 1 and 2 | 1 and 2 | 1 and 2 |
 | Visit type | Inclusion | Run-in | Baseline | Follow up | Follow up |
Activity/Assesment | Â | Â | Â | Â | Â | Â |
Live | Â | x | x | x | Â | x |
Telephone | Â | Â | Â | Â | x | Â |
Check inclusion criteria | Â | x | Â | Â | Â | Â |
Informed consent | Â | x | Â | Â | Â | Â |
Medication check | Â | x | Â | Â | Â | Â |
Prior medical history | Â | x | Â | Â | Â | Â |
Comorbidities | Â | x | Â | Â | Â | Â |
Anthropometrics | Â | x | Â | x | Â | x |
Exacerbation frequency | Â | x | x | x | x | x |
Questionnaires | Â | x | x | x | x | x |
Blood samples | Â | Â | Â | x | Â | x |
Scalp Hair | Â | Â | Â | x | Â | x |
Lung function test* | Â | Â | x | x | Â | x |
eNose | Â | Â | Â | x | Â | x |
Study information | Â | x | x | x | x | x |
Prescriptions | Â | Â | x | x | x | x |
SAE form | Â | Thoughout study |